Second Look at Drug Patents Act of 2020
This bill imposes additional patent reporting requirements on the manufacturers of certain drugs approved by the Federal Drug Administration.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.